|

Tazemetostat Pill Clinical Trials

1 actively recruiting trial across 1 location

No change since May 2026

Also known as: Tazverik

Pipeline

Phase 1: 1

Top Sponsors

  • Weill Medical College of Cornell University1

Indications

  • B Cell Lymphoma1
  • Mantle Cell Lymphoma1
  • Diffuse Large B-Cell Lymphoma1
  • Follicular Lymphoma1
  • Cancer1

New York, New York1 trial

A Feasibility Trial of Tazemetostat Plus CAR T Cell Therapy in B-cell Lymphomas

Weill Cornell Medicine/NewYork-Presbyterian Hospital

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.